Akari Therapeutics (AKTX) Short-term Investments (2016 - 2019)
Akari Therapeutics recorded quarterly Short-term Investments of $17364.0 in Q2 2019, down 88.26% quarter-over-quarter from $147924.0 in Q1 2019, and down 96.67% year-over-year from $521408.0 in Q2 2018.
Akari Therapeutics' Short-term Investments history runs 4 years deep, the most recent figure standing at $17364.0 for Q2 2019.
- In Q2 2019, Short-term Investments fell 96.67% year-over-year to $17364.0; the TTM figure through Jun 2019 stood at $17364.0 (down 96.67% YoY), while the FY2018 annual figure was $521829.0, up 266.88% from the prior year.
- Short-term Investments came in at $17364.0 for Q2 2019 at Akari Therapeutics, down from $147924.0 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $46.1 million in Q2 2016 to a low of $17364.0 in Q2 2019.
- A 4-year average of $9.5 million and a median of $521514.0 in 2018 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments sank 99.68% in 2017 and soared 266.88% in 2018, its largest moves.
- Akari Therapeutics' Short-term Investments stood at $10.0 million in 2016, then plunged by 98.58% to $142235.0 in 2017, then jumped by 266.88% to $521829.0 in 2018, then sank by 96.67% to $17364.0 in 2019.
- According to Business Quant data, Short-term Investments over the past three periods registered $17364.0, $147924.0, and $521829.0 for Q2 2019, Q1 2019, and Q4 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 17,364.00 |
| Mar 31, 2019 | 147,924.00 |
| Dec 31, 2018 | 521,829.00 |
| Sep 30, 2018 | 521,620.00 |
| Jun 30, 2018 | 521,408.00 |
| Mar 31, 2018 | 142,253.00 |
| Dec 31, 2017 | 142,235.00 |
| Sep 30, 2017 | 142,218.00 |
| Mar 31, 2017 | 10.02 Mn |
| Dec 31, 2016 | 10.02 Mn |
| Sep 30, 2016 | 45.10 Mn |
| Jun 30, 2016 | 46.12 Mn |